Life Sciences
Our Global Life Sciences sector can help you navigate forward and achieve sustainable success in the new health-outcomes-driven ecosystem.
Aging populations and chronic disease are putting pressure on health resources around the world just as scientific progress, augmented intelligence and digital data are transforming the traditional health care models. This is causing a power shift with new entrants (often not driven by profit) disrupting the incumbents.
Staying competitive and providing the personalized experience that patients demand require life sciences organizations to find new ways of working. Partnering with others to share data, medicine and resources while anticipating trends and regulatory changes will help ensure sustainability in the increasingly evidence-based, outcomes-focused sector.
We help companies across the biotechnology, pharmaceutical and medical technology fields harness this disruption by forming the right alliances, better allocating resources and building trust with customers.
Rapid developments in the pharmaceutical industry require the adaptation of EU legislations.
Find out at what the upcoming regulatory change means for Swiss Life Sciences Companies and what effects are to be expected.
Our latest thinking
Whitepaper: Evidence generation in medical affairs
Evidence generation, a case for change in value demonstration and a key to unlock the future of the medical affairs organization.
